WELCOME TO
BSG LIVE’25

Connect • Learn Innovate

Industry Symposia – Madrigal Pharmaceuticals

MASH with Fibrosis: Defining Risk and Clinical Pathways for Decision Making

Wednesday 24 June 13:00-13:40

Learning objectives:

  • Recognise the burden of disease for patients living with MASH with liver fibrosis
  • Summarise a stepwise diagnostic algorithm supporting the identification of patients with non-cirrhotic MASH with moderate to advanced liver fibrosis
  • Describe the clinical decision making in MASH

Speakers:

Dr Thomas Marjot – Consultant Hepatologist, King’s College Hospital

BACK